Molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Park, Sun H ^a   Byun, Ji Hyun ^b   Choi, Su Mi ^a   Lee, Dong Gun ^a   Kim, Si Hyun ^c   Kwon, Jae Cheol ^d   Park, Chulmin ^b   Choi, Jung Hyun ^a   Yoo, Jin Hong ^a,e  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Korea University College of Medicine   (South Korea)

^d Ilsan Hospital   (South Korea)

^e The Catholic University of Korea   (South Korea)

Author keywords

Community; Escherichia coli; Extended spectrum lactamse; Korea; Molecular epidemiology

Indexed keywords

AMIKACIN; BETA LACTAMASE CTX M; CEFTAZIDIME; CIPROFLOXACIN; COTRIFAMOLE; GENTAMICIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENETICS; BACTERIAL TRANSMISSION; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CHILD; COMMUNITY; CONTROLLED STUDY; EPIDEMIC; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; GENETIC HETEROGENEITY; GEOGRAPHICAL VARIATION (SPECIES); HOSPITAL; HOSPITAL INFECTION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PULSED FIELD GEL ELECTROPHORESIS; SOUTH KOREA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BETA-LACTAMASES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HOSPITALS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; POLYMERASE CHAIN REACTION; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84862982969     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-149     Document Type: Article

References (35)

1. Pitout JD, Laupland KB. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008, 8(3):159-166. 10.1016/S1473-3099(08)70041-0, 18291338.
2. Woodford N, Ward ME, Kaufmann ME, Turton J, Fagan EJ, James D, Johnson AP, Pike R, Warner M, Cheasty T, et al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK. J Antimicrob Chemother 2004, 54(4):735-743. 10.1093/jac/dkh424, 15347638.
3. Rogers BA, Sidjabat HE, Paterson DL. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 2011, 66(1):1-14. 10.1093/jac/dkq415, 21081548.
4. Coque TM, Novais A, Carattoli A, Poirel L, Pitout J, Peixe L, Baquero F, Canton R, Nordmann P. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15. Emerg Infect Dis 2008, 14(2):195-200. 10.3201/eid1402.070350, 2600198, 18258110.
5. Peirano G, Costello M, Pitout JD. Molecular epidemiology over an 11-year period (2000 to 2010) of extended-spectrum β-lactamase-P\producing Escherichia coli causing bacteremia in a centralized Canadian region. Int J Antimicrob Agents 2010, 36(1):19-23. 10.1016/j.ijantimicag.2010.02.016, 20359869.
6. Smet A, Martel A, Persoons D, Dewulf J, Heyndrickx M, Claeys G, Lontie M, Van Meensel B, Herman L, Haesebrouck F, et al. Characterization of extended-spectrum β-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections. Microb Drug Resist 2010, 16(2):129-134. 10.1089/mdr.2009.0132, 20370505.
7. Pitout JD, Gregson DB, Campbell L, Laupland KB. Molecular characteristics of extended-spectrum-β-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections. Antimicrob Agents Chemother 2009, 53(7):2846-2851. 10.1128/AAC.00247-09, 2704701, 19380595.
8. Peirano G, van der Bij AK, Gregson DB, Pitout JD. Molecular Epidemiology over an 11-Year Period (2000 to 2010) of Extended-Spectrum β-Lactamase-Producing Escherichia coli Causing Bacteremia in a Centralized Canadian Region. J Clin Microbiol 2012, 50(2):294-299. 10.1128/JCM.06025-11, 3264152, 22162555.
9. Croxall G, Hale J, Weston V, Manning G, Cheetham P, Achtman M, McNally A. Molecular epidemiology of extraintestinal pathogenic Escherichia coli isolates from a regional cohort of elderly patients highlights the prevalence of ST131 strains with increased antimicrobial resistance in both community and hospital care settings. J Antimicrob Chemother 2011, 66(11):2501-2508. 10.1093/jac/dkr349, 21862477.
10. Naseer U, Sundsfjord A. The CTX-M conundrum: dissemination of plasmids and Escherichia coli clones. Microb Drug Resist 2011, 17(1):83-97. 10.1089/mdr.2010.0132, 21281129.
11. Ko KS, Lee MY, Song JH, Lee H, Jung DS, Jung SI, Kim SW, Chang HH, Yeom JS, Kim YS, et al. Prevalence and characterization of extended-spectrum β-lactamase-producing Enterobacteriaceae isolated in Korean hospitals. Diagn Microbiol Infect Dis 2008, 61(4):453-459. 10.1016/j.diagmicrobio.2008.03.005, 18482815.
12. Lee SG, Jeong SH, Lee H, Kim CK, Lee Y, Koh E, Chong Y, Lee K. Spread of CTX-M-type extended-spectrum β-lactamases among bloodstream isolates of Escherichia coli and Klebsiella pneumoniae from a Korean hospital. Diagn Microbiol Infect Dis 2009, 63(1):76-80. 10.1016/j.diagmicrobio.2008.09.002, 19073302.
13. Shin J, Kim DH, Ko KS. Comparison of CTX-M-14- and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae isolates from patients with bacteremia. J Infect 2011, 63(1):39-47. 10.1016/j.jinf.2011.05.003, 21712135.
14. Kim MH, Lee HJ, Park KS, Suh JT. Molecular characteristics of extended spectrum β-lactamases in Escherichia coli and Klebsiella pneumoniae and the prevalence of qnr in extended spectrum β-lactamase isolates in a tertiary care hospital in Korea. Yonsei Med J 2010, 51(5):768-774. 10.3349/ymj.2010.51.5.768, 2908884, 20635454.
15. Kang CI, Wi YM, Lee MY, Ko KS, Chung DR, Peck KR, Lee NY, Song JH. Epidemiology and risk factors of community onset infections caused by extended-spectrum β-lactamase-producing Escherichia coli strains. J Clin Microbiol 2012, 50(2):312-317. 10.1128/JCM.06002-11, 3264158, 22162561.
16. Lee MY, Choi HJ, Choi JY, Song M, Song Y, Kim SW, Chang HH, Jung SI, Kim YS, Ki HK, et al. Dissemination of ST131 and ST393 community-onset, ciprofloxacin-resistant Escherichia coli clones causing urinary tract infections in Korea. J Infect 2010, 60(2):146-153. 10.1016/j.jinf.2009.11.004, 19932131.
17. Kang CI, Song JH, Chung DR, Peck KR, Ko KS, Yeom JS, Ki HK, Son JS, Lee SS, Kim YS, et al. Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum β-lactamase-producing Escherichia coli. Int J Antimicrob Agents 2010, 36(3):284-287. 10.1016/j.ijantimicag.2010.05.009, 20580534.
18. Park SH, Choi SM, Lee DG, Kim J, Choi JH, Kim SH, Kwon JC, Yoo JH. Emergence of extended-spectrum β-lactamase-producing Escherichia coli as a cause of community-onset bacteremia in South Korea: risk factors and clinical outcomes. Microb Drug Resist 2011, 17(4):537-544. 10.1089/mdr.2011.0072, 21875342.
19. Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing: 20th informational supplement, CLSI document M100-S20 2010, Wayne, CLSI.
20. Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing: 19th informational supplement, CLSI document M100-S19 2009, Wayne, CLSI.
21. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012, 18(3):268-281. 10.1111/j.1469-0691.2011.03570.x, 21793988.
22. Rodriguez-Bano J, Picon E, Gijon P, Hernandez JR, Cisneros JM, Pena C, Almela M, Almirante B, Grill F, Colomina J, et al. Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-β-lactamase-producing Escherichia coli. J Clin Microbiol 2010, 48(5):1726-1731. 10.1128/JCM.02353-09, 2863889, 20181897.
23. Ben-Ami R, Schwaber MJ, Navon-Venezia S, Schwartz D, Giladi M, Chmelnitsky I, Leavitt A, Carmeli Y. Influx of extended-spectrum β-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis 2006, 42(7):925-934. 10.1086/500936, 16511754.
24. Eckert C, Gautier V, Arlet G. DNA sequence analysis of the genetic environment of various blaCTX-M genes. J Antimicrob Chemother 2006, 57(1):14-23.
25. Ribot EM, Fair MA, Gautom R, Cameron DN, Hunter SB, Swaminathan B, Barrett TJ. Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog Dis 2006, 3(1):59-67. 10.1089/fpd.2006.3.59, 16602980.
26. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995, 33(9):2233-2239. 228385, 7494007.
27. Lau SH, Reddy S, Cheesbrough J, Bolton FJ, Willshaw G, Cheasty T, Fox AJ, Upton M. Major uropathogenic Escherichia coli strain isolated in the northwest of England identified by multilocus sequence typing. J Clin Microbiol 2008, 46(3):1076-1080. 10.1128/JCM.02065-07, 2268376, 18199778.
28. CDC/NHSN Surveillance Definition of Healthcare-Associated Infection and Criteria for Specific Types of Infections in the Acute Care Setting http://www.cdc.gov/nhsn/PDFs/pscManual/17pscNosInfDef_current.pdf.
29. Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002, 137(10):791-797.
30. Rodrguez-Bano J, Picn E, Gijn P, Hernndez JR, Ruz M, Pea C, Almela M, Almirante B, Grill F, Colomina J, et al. Community-onset bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: risk factors and prognosis. Clin Infect Dis 2010, 50(1):40-48. 10.1086/649537, 19995215.
31. Pitout JD, Church DL, Gregson DB, Chow BL, McCracken M, Mulvey MR, Laupland KB. Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates. Antimicrob Agents Chemother 2007, 51(4):1281-1286. 10.1128/AAC.01377-06, 1855502, 17283198.
32. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, Canica MM, Park YJ, Lavigne JP, Pitout J, Johnson JR. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2008, 61(2):273-281.
33. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis 2010, 51(3):286-294. 10.1086/653932, 20572763.
34. Paniagua R, Valverde A, Coque TM, Baquero F, Canton R. Assessment of prevalence and changing epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae fecal carriers using a chromogenic medium. Diagn Microbiol Infect Dis 2010, 67(4):376-379. 10.1016/j.diagmicrobio.2010.03.012, 20638607.
35. Kim J, Bae IK, Jeong SH, Chang CL, Lee CH, Lee K. Characterization of IncF plasmids carrying the blaCTX-M-14 gene in clinical isolates of Escherichia coli from Korea. J Antimicrob Chemother 2011, 66(6):1263-1268. 10.1093/jac/dkr106, 21415040.